Red Leaf Medical Inc. has signed an exclusive agreement with Lenus Pharma, a leading Austrian pharmaceutical company specializing in fertility, to commercialize PROfortil™ in Canada. PROfortil™ is a clinically proven treatment that contains a patented composition of micronutrients that aid in fertility.

Canadian Business and PROFIT today listed Red Leaf Medical Inc. on the 28th annual PROFIT 500, the definitive ranking of Canada’s Fastest-Growing Companies.

Biotechnology Focus, a leading Life Sciences Publication in Canada, has profiled Red Leaf Medical as an innovative company building a strong reputation with great products and a passionate focus on meeting patients’ needs.

Canadian Business and PROFIT today ranked Red Leaf Medical No. 38 on the 27th annual PROFIT 500, the definitive ranking of Canada’s Fastest-Growing Companies.